Literature DB >> 12788964

Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease?

A D Struthers1, J Davies.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12788964     DOI： 10.1093/qjmed/hcg067

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  3 in total

1.  Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis.

Authors:  Michael J Twiner; Alexander L Marinica; Kenneth Kuper; Allen Goodman; James J Mahn; Michael J Burla; Aaron M Brody; Justin A Carroll; Robina Josiah Willock; John M Flack; Samar A Nasser; Phillip D Levy
Journal:  Acad Emerg Med       Date:  2017-01-30       Impact factor: 3.451

2.  Spectrum of cardiac abnormalities associated with long QT in stroke survivors.

Authors:  K Y K Wong; S McSwiggan; N S J Kennedy; S Y S Wong; A Gavin; R S MacWalter; A D Struthers
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

3.  Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis.

Authors:  Helen M Parry; Louise A Donnelly; Natalie Van Zuydam; Alexander Sf Doney; Douglas Hj Elder; Andrew D Morris; Alan D Struthers; Colin Na Palmer; Chim C Lang
Journal:  Cardiovasc Diabetol       Date:  2013-07-23       Impact factor: 9.951
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.